Introducing high‐flow nasal cannula to the neonatal transport environment

Boyle, Michael A; Dhar, A; Chaudhary, Rajiv; Kent, Susan; O'Hare, Sarah; Dassios, Theodore; Broster, S

doi:10.1111/apa.13702

Cited by 11 publications

(7 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…102 Recommendation notes: The use of HFNC for neonatal transport is increasing. 100,103 The limited available evidence suggests that HFNC is relatively safe for neonatal transport. 100,103 The condition and risk of the patient must be assessed before transfer.…”

Section: Recommendation 7: Hfnc Can Be Used For Neonatal Transport Of...mentioning

confidence: 99%

“…100,103 The limited available evidence suggests that HFNC is relatively safe for neonatal transport. 100,103 The condition and risk of the patient must be assessed before transfer. A retrospective study (n = 195) found that patients potentially requiring escalation of respiratory support had the following characteristics: higher pre-transfer FiO 2 (0.60 (0.36−1.00) vs. 0.36 (0.23−0.56)) and lower pre-transfer peripheral capillary oxygen saturation/fraction of inspired oxygen (SpO 2 /FiO 2 < 200).…”

Section: Recommendation 7: Hfnc Can Be Used For Neonatal Transport Of...mentioning

confidence: 99%

See 1 more Smart Citation

Guidelines for high‐flow nasal cannula oxygen therapy in neonates (2022)

Huang,

Zhao,

Hua

et al. 2023

J Evidence Based Medicine

View full text Add to dashboard Cite

High‐flow nasal cannula (HFNC) oxygen therapy, which is important in noninvasive respiratory support, is increasingly being used in critically ill neonates with respiratory failure because it is comfortable, easy to setup, and has a low incidence of nasal trauma. The advantages, indications, and risks of HFNC have been the focus of research in recent years, resulting in the development of the application. Based on current evidence, we developed guidelines for HFNC in neonates using the Grading of Recommendations Assessment, Development and Evaluation (GRADE). The guidelines were formulated after extensive consultations with neonatologists, respiratory therapists, nurse specialists, and evidence‐based medicine experts. We have proposed 24 recommendations for 9 key questions. The guidelines aim to be a source of evidence and reference of HFNC oxygen therapy in clinical practice, and so that more neonates and their families will benefit from HFNC.

show abstract

Section: Recommendation 7: Hfnc Can Be Used For Neonatal Transport Of...mentioning

confidence: 99%

Section: Recommendation 7: Hfnc Can Be Used For Neonatal Transport Of...mentioning

confidence: 99%

Guidelines for high‐flow nasal cannula oxygen therapy in neonates (2022)

Huang,

Zhao,

Hua

et al. 2023

J Evidence Based Medicine

View full text Add to dashboard Cite

show abstract

“…We report nHF use primarily for emergency transport (86% of our population). Two British neonatal transport services have reported their experience with nHF; most transfers were elective, and infants were required to be stable on nHF for 24 hours to be eligible for transfer on nHF .…”

Section: Infant Demographics and Outcomesmentioning

confidence: 99%

Nasal high‐flow during neonatal and infant transport in Victoria, Australia

et al. 2019

View full text Add to dashboard Cite

“…The use of nHF in elective and emergency neonatal transport has been reported in one UK study of 102 infants. Whilst no comparison was made with transports on CPAP, the authors reported a very small (2%) increase in oxygen requirement during transport on nHF, and it was believed to be safe and effective.…”

Section: Future Research Directionsmentioning

confidence: 99%

Nasal high flow therapy for neonates: Current evidence and future directions

Hodgson

Davis

Owen

2019

J Paediatrics Child Health

View full text Add to dashboard Cite

Nasal high flow (nHF) therapy is a commonly used method of providing non‐invasive respiratory support for neonates. It has several potential mechanisms of action: continuous distending pressure, nasopharyngeal dead space washout, provision of heated and humidified gases and reduction of work of breathing. nHF is used in a number of clinical scenarios for preterm and term infants, including primary respiratory and post‐extubation support. In recent years, large trials have generated evidence pertinent to these indications. Novel applications for nHF in neonates warrant further research: during endotracheal intubation, for initial delivery room stabilisation of preterm infants and in conjunction with minimally invasive surfactant therapy.

show abstract

Introducing high‐flow nasal cannula to the neonatal transport environment

Cited by 11 publications

References 13 publications

Guidelines for high‐flow nasal cannula oxygen therapy in neonates (2022)

Guidelines for high‐flow nasal cannula oxygen therapy in neonates (2022)

Nasal high‐flow during neonatal and infant transport in Victoria, Australia

Nasal high flow therapy for neonates: Current evidence and future directions

Contact Info

Product

Resources

About